4-Phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets

This publication has 20 references indexed in Scilit:

• Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse
  Neuroscience Letters, 1986
• Persistent depletion of striatal dopamine in mice by 1-Methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP)
  Biochemical Pharmacology, 1986
• The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety
  Neuroscience Letters, 1985
• Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice
  Neuroscience Letters, 1985
• METHYLTETRAHYDRO-β-CARBOLINES AND PARKINSON'S DISEASE
  The Lancet, 1985
• β-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?
  Neuroscience Letters, 1985
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig
  Life Sciences, 1985
• VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicity
  Life Sciences, 1985
• The importance of the ‘4–5’ double bond for neurotoxicity in primates of the pyridine derivative MPTP
  Neuroscience Letters, 1984
• The current neurologic burden of illness and injury in the United States
  Neurology, 1982